The PTC124 (Ataluren) Clinical Trial for Duchenne Muscular Dystrophy: Exploration of the Experiences of Parents, Clinician Researchers, and the Industry Sponsor
This study has been completed.
National Human Genome Research Institute (NHGRI)
First Posted: August 16, 2010
Last Update Posted: July 2, 2017
Information provided by:
National Institutes of Health Clinical Center (CC)